Tower Research Capital LLC (TRC)
Position in COGT — Cogent Biosciences, Inc.
CIK 1533421
NEW YORK, NY
Position in COGT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$388,354
-$358,235 QoQ
Shares Held
10,035
-48.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#219
of 323 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. COGT ranks #24 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in COGT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $388,354 | 10,035 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $746,589 | 19,397 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $268,637 | 7,563 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $105,990 | 7,381 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $127,839 | 17,805 | Shares | Other | 2025-08-15 | |
| 2025-03-31 | $31,099 | 5,192 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $94,902 | 12,167 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $6,534 | 605 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $188,528 | 22,364 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,766 | 2,644 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $234,352 | 39,856 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $28,440 | 2,917 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $22,945 | 1,938 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $32,693 | 3,030 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $36,043 | 3,118 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $49,967 | 3,349 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $27,294 | 3,026 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $18,147 | 2,423 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $12,372 | 1,442 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $23,707 | 2,819 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $66,209 | 8,164 | Shares | Other | 2021-08-16 | |
| 2020-09-30 UMRX | — | 9,069 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 UMRX | — | 16,389 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||